Endothelin Receptor Antagonism: A New Era in the Treatment of Pulmonary Arterial Hypertension
暂无分享,去创建一个
[1] D. Badesch,et al. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study , 2001, The Lancet.
[2] C. Pedersen,et al. Endothelin mediates pulmonary vascular remodelling in a canine model of chronic embolic pulmonary hypertension. , 2000, The European respiratory journal.
[3] B. Groves,et al. Continuous infusion of epoprostenol improves the net balance between pulmonary endothelin-1 clearance and release in primary pulmonary hypertension. , 1999, Circulation.
[4] Yue-ying Gu,et al. Pulmonary hypertension in systemic lupus erythematosus , 1999, Rheumatology International.
[5] G. Karabıyıkoğlu,et al. Local and Peripheral Plasma Endothelin-1 in Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease , 1998, Respiration.
[6] Z. Li,et al. Plasma endothelin 1 concentrations in children with congenital heart defects. , 1998, Minerva pediatrica.
[7] D. Stewart,et al. Human pulmonary circulation is an important site for both clearance and production of endothelin-1. , 1996, Circulation.
[8] S. Kira,et al. Effects of separate and combined ETA and ETB blockade on ET-1-induced constriction in perfused rat lungs. , 1995, The American journal of physiology.
[9] G. Valesini,et al. Plasma endothelin-1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis. , 1995, The American journal of medicine.
[10] P. Henry,et al. Receptors for endothelin‐1 in asthmatic human peripheral lung , 1995, British journal of pharmacology.
[11] M. Yacoub,et al. Localization and Characterization of Endothelin‐1 Binding Sites in the Transplanted Human Lung , 1995, Journal of cardiovascular pharmacology.
[12] A. Davenport,et al. Characterization of Endothelin Receptors in the Human Pulmonary Vasculature Using Bosentan, SB209670, and 97–139 , 1995, Journal of cardiovascular pharmacology.
[13] M. Sheppard,et al. Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis , 1993, The Lancet.
[14] D. Stewart,et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. , 1993, The New England journal of medicine.
[15] P. Binkley,et al. Plasma Endothelin Correlates With the Extent of Pulmonary Hypertension in Patients With Chronic Congestive Heart Failure , 1992, Circulation.
[16] D. Stewart,et al. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? , 1991, Annals of internal medicine.
[17] A. Davenport,et al. Endothelin-1 mRNA is widely expressed in porcine and human tissues. , 1990, The Journal of clinical investigation.
[18] J. Vane,et al. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.